ATP2B1 and cardiomyopathy: The PLCE1-rs932764-G and ATP2B1-rs17249754-G variants, known for their role in hypertension, were significantly associated with a decreasing risk of cardiomyopathy (p = 0.006 and 0.04, respectively) [32].